| | [4-[[5-Chloro-4-(MethylaMino)-2-pyriMidinyl]aMino]-3-Methoxyphenyl]-4-MorpholinylMethanone|[4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-嗎啉基甲酮 基本信息 更多信息 |
| 中文名稱: | [4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-嗎啉基甲酮 | | 中文同義詞: | [4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-嗎啉基甲酮;(4-((5-氯-4-(甲氨基)嘧啶-2-基)氨基)-3-甲氧基苯基)(嗎啉)甲酮;化合物HG-10-102-01;(4-((5-氯-4-(甲氨基)嘧啶-2-基)氨基)-3-甲氧基苯基)(嗎啉代)甲酮;化合物HG-10-102-01,10 MM DMSO 溶液;HG-10-102-01 ,S2948 | | 英文名稱: | [4-[[5-Chloro-4-(MethylaMino)-2-pyriMidinyl]aMino]-3-Methoxyphenyl]-4-MorpholinylMethanone | | 英文同義詞: | [4-[[5-Chloro-4-(MethylaMino)-2-pyriMidinyl]aMino]-3-Methoxyphenyl]-4-MorpholinylMethanone;HG-10-102-01;(4-((5-chloro-4-
(methylamino)pyrimidin-2-yl)amino)-
3-
methoxyphenyl)(morpholino)methano
ne;Methanone, [4-[[5-chloro-4-(methylamino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-morpholinyl-;CS-949;LRRK2 INHIBITOR 1;Parkinson’s disease,Leucine-rich repeat kinase 2,inhibit,Ser910,BBB,HG 10 102 01,Radiosynthesis,Mouse embryonic fibroblast cells,Mouse Swiss 3T3 cells,MAP kinase interacting kinase,Ser935,MNK,Mitogen activated protein kinase interacting kinase,HG1010201,PET,Inhibitor,MAPK interacting kinase,HEK293 cells,LRRK2,Positron emission tomography;HG-10-102-01, 10 mM in DMSO | | CAS號: | 1351758-81-0 | | 分子式: | C17H20ClN5O3 | | 分子量: | 377.83 | | EINECS號: | | ![[4-[[5-Chloro-4-(MethylaMino)-2-pyriMidinyl]aMino]-3-Methoxyphenyl]-4-MorpholinylMethanone|[4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-嗎啉基甲酮](/CAS/GIF/1351758-81-0.gif) |
|
| 按國家瀏覽[4-[[5-Chloro-4-(MethylaMino)-2-pyriMidinyl]aMino]-3-Methoxyphenyl]-4-MorpholinylMethanone國外供應商 |
中國供應商 |
|
[4-[[5-Chloro-4-(MethylaMino)-2-pyriMidinyl]aMino]-3-Methoxyphenyl]-4-MorpholinylMethanone 推薦供應商 |
|
|
建議您優(yōu)先選擇企業(yè)會員,我們對企業(yè)會員產品有嚴格審核。 |
|
|